KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Average (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Equity Average for 16 consecutive years, with $48.2 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Equity Average rose 8.12% year-over-year to $48.2 billion, compared with a TTM value of $48.2 billion through Sep 2024, up 8.12%, and an annual FY2023 reading of $45.4 billion, up 6.91% over the prior year.
  • Equity Average was $48.2 billion for Q3 2024 at Thermo Fisher Scientific, up from $46.5 billion in the prior quarter.
  • Across five years, Equity Average topped out at $48.2 billion in Q3 2024 and bottomed at $29.1 billion in Q1 2020.
  • Average Equity Average over 5 years is $39.9 billion, with a median of $41.7 billion recorded in 2022.
  • The sharpest move saw Equity Average grew 23.16% in 2021, then rose 3.29% in 2023.
  • Year by year, Equity Average stood at $33.2 billion in 2020, then rose by 20.0% to $39.8 billion in 2021, then increased by 10.08% to $43.8 billion in 2022, then increased by 5.05% to $46.0 billion in 2023, then rose by 4.69% to $48.2 billion in 2024.
  • Business Quant data shows Equity Average for TMO at $48.2 billion in Q3 2024, $46.5 billion in Q2 2024, and $46.1 billion in Q1 2024.